Share-Based Compensation Plans - Schedule of Transactions Involving Outstanding Non-Options Awards (Details)
|
3 Months Ended |
|
Feb. 02, 2020
$ / shares
shares
|
|---|
| Equity and Liability Awards, Performance Share Units |
|
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] |
|
| Number of shares, Outstanding Ending balance (shares) | shares |
376,986
|
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] |
|
| Weighted average grant date fair value, Outstanding (usd per share) | $ / shares |
$ 3.90
|
| Equity and Liability Awards, Restricted Stock Units |
|
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] |
|
| Number of shares, Outstanding Beginning balance (shares) | shares |
667,082
|
| Number of shares, Forfeited (shares) | shares |
(4,387)
|
| Number of shares, Vested (shares) | shares |
(9,485)
|
| Number of shares, Outstanding Ending balance (shares) | shares |
653,210
|
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] |
|
| Weighted average grant date fair value, Outstanding (usd per share) | $ / shares |
$ 3.86
|
| Weighted average grant date fair value, Forfeited (usd per share) | $ / shares |
3.80
|
| Weighted average grant date fair value, Vested (usd per share) | $ / shares |
4.10
|
| Weighted average grant date fair value, Outstanding (usd per share) | $ / shares |
$ 3.86
|